Back to Search
KAWAL CHESTER, M.D.
M.D.
Medical Oncology Physician
NPI: 1619963600Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD00038751(WA)
Research & Publications (20)
Site-specific polysialylation of an antitumor single-chain Fv fragment.
PMID 19402707·Bioconjug Chem·2009
7-preclinical
Data standards for minimum information collection for antibody therapy experiments.
PMID 19224941·Protein Eng Des Sel·2009
7-preclinical
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas.
PMID 19549771·Clin Cancer Res·2009
3-trial
Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments.
PMID 17973256·Int J Cancer·2008
7-preclinical
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus.
PMID 18656482·J Mol Biol·2008
7-preclinical
From laboratory to Phase I/II cancer trials with recombinant biotherapeutics.
PMID 17933516·Eur J Cancer·2007
6-review
Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy.
PMID 17000699·Glycobiology·2007
7-preclinical
Production of recombinant protein in Pichia pastoris by fermentation.
PMID 17406338·Nat Protoc·2006
8-other
Expanded-bed adsorption immobilized-metal affinity chromatography.
PMID 17406404·Nat Protoc·2006
8-other
Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis.
PMID 17158431·Am J Clin Nutr·2006
3-trial
Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer.
PMID 17115389·Br J Surg·2006
6-review
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug.
PMID 17085666·Clin Cancer Res·2006
3-trial
Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen.
PMID 16678252·Int J Biol Macromol·2006
8-other
Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy.
PMID 15701872·Clin Cancer Res·2005
7-preclinical
Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT).
PMID 15162148·Br J Cancer·2004
3-trial
Engineered single chain antibody fragments for radioimmunotherapy.
PMID 15640791·Q J Nucl Med Mol Imaging·2004
7-preclinical
Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis.
PMID 15332224·Am J Kidney Dis·2004
4-observational
Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C.
PMID 15115853·Protein Eng Des Sel·2004
8-other
Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with 99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT).
PMID 15029458·Eur J Nucl Med Mol Imaging·2004
7-preclinical
Radiometal labeling of antibodies and antibody fragments for imaging and therapy.
PMID 14970515·Methods Mol Biol·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 605 E HOLLAND AVE, SUITE 100
SPOKANE, WA 99218 - Phone
- (509) 228-1000
Quick Facts
- NPI
- 1619963600
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile